Premium
Hospital pharmacists' beliefs about optimising statin therapy in older inpatients
Author(s) -
Wu Angela,
Reeve Emily,
Hilmer Sarah,
Gnjidic Danijela
Publication year - 2017
Publication title -
journal of pharmacy practice and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 22
eISSN - 2055-2335
pISSN - 1445-937X
DOI - 10.1002/jppr.1264
Subject(s) - medicine , deprescribing , statin , polypharmacy , clinical pharmacy , pharmacotherapy , family medicine , physical therapy , emergency medicine , pharmacy , intensive care medicine , nursing
This study explored hospital pharmacists’ perspectives about optimising statin therapy in older inpatients in Australia. An anonymous questionnaire using standardised questions in the form of five‐point Likert scales to capture pharmacists’ attitudes toward their role in statin optimisation, compliance of statin therapy with existing guidelines, knowledge of statin‐related side effects and clinical recommendations such as starting and ceasing or deprescribing therapy, was administered. A total of 108 hospital pharmacists across Australia completed the questionnaire. Over 90% of hospital pharmacists agreed that they had an important role in managing statin therapy in older inpatients (95% CI: 90.5–98.8%). Less than 40% agreed that statin therapy in older adults was prescribed in accordance with Australian clinical guidelines (95% CI: 27.4–47.6%), and over 90% agreed that there was a need for statin deprescribing guidelines for older adults (95% CI: 85.7–97.6%). Hospital pharmacists believe that they have an important role in optimising statin therapy.